
Allogene Therapeutics
A biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
HQ location
San Francisco, United States
Website
Launch date
Employees
Market cap
$258m
Enterprise value
$59m
Share price
$1.13 ALLO
Recent deals
Authorizing premium user...